Home  Contact Us
  Follow Us On:
Advertising Advertising Free Newsletter Free E-Newsletter

Merck COVID treatment priced at 1,500 yuan per bottle in Tianjin
Published on: 2023-01-12
Share to
User Rating: / 0

Merck & Co's COVID-19 antiviral treatment molnupiravir was priced at 1,500 yuan per bottle in Tianjin, according to the medical purchasing centre on Tuesday.

Each bottle contains 40 pills - enough for one course of treatment - according to the centre. The treatment, which is sold under the brand name Lagevrio, was approved for adults with mild to medium COVID infections and a high risk of progressing to severe cases.

China granted conditional approval for the import of molnupiravir, which was developed by Merck and partner Ridgeback Biotherapeutics. Merck has a deal in place for China's Sinopharm to import and distribute the medication.



Comments (0)Add Comment

Write comment

security code
Write the displayed characters

    Subscription    |     Advertising    |     Contact Us    |
Address: Magnetic Plaza, Building A4, 6th Floor, Binshui Xi Dao.
Nankai District. 300381 TIANJIN. PR CHINA
Tel: +86 22 23917700
E-mail: webmaster@businesstianjin.com
Copyright 2024 BusinessTianjin.com. All rights reserved.